*We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies.

skip to main content

DEAL OF THE YEAR AWARD SCOOPED FOR CAMBRIDGE BIOMEDICAL CAMPUS

Share this page

16/12/2014

 

Joint venture partners, Countryside and Liberty Property Trust have won the Deal of the Year – Industry Impact Award at the 2014 Estates Gazette Awards. In what is believed to be the largest ever single private sector forward-sale transaction outside central London.

Deal of the Year award scooped for Cambridge Biomedical Campus

Pharmaceutical giant AstraZeneca will establish its global research and development and corporate headquarters on the Cambridge Biomedical Campus, a facility that will extend to almost 900,000 sq ft, employing 2,000 people.

The award recognises the wide-reaching impact of the deal which is unprecedented in terms of its implications not just for AstraZeneca, its supply chain, and the global pharmaceutical industry, but the UK economy, patients and healthcare providers around the world.

The awards praised Liberty Property Trust and Countryside’s, ‘extraordinary vision, ambition and investment’, with over £40 million of new campus infrastructure being provided. By locating on the campus, AstraZeneca will work closely with the world-leading academics and clinicians on site with the goal of bringing new and affordable medicines to patients.

The impact of the deal on the Cambridge economy is unprecedented. For each of the 2,000 people to be employed by AstraZeneca, it is estimated that another 2-3 jobs could be created. This ranges from jobs in allied services such as legal, financial, regulatory, recruitment and consulting to jobs in areas such as hotels, taxi firms, catering and leisure facilities.

In the past, Cambridge has proved to be an attractive location for research and development but has not typically attracted the global headquarters of multinational corporations. AstraZeneca’s decision to locate its corporate headquarters on the campus alongside its research and development centre will help to broaden the skills base in the Cambridge sub-region and may result in other companies moving their headquarters to the city.

Andrew Blevins, MD of Liberty Property Trust UK, said: “We are thrilled that the work we have been doing with our partners, Countryside, has been recognised. AstraZeneca’s decision to locate at Cambridge Biomedical Campus will have benefits that extend beyond the city, science and property industries and reach far into the future. The effects of this collaborative community will be felt for generations in the new concepts, drugs and discoveries which are made there.”

For further information visit http://cambridge-biomedical.com/ 

ENDS


Share this page

News subscription

Select the alerts that you would like to receive


Your contact details

First name:*
Last name:*
Email address:*

* denotes required fields

You can change your preferences or unsubscribe at any time.